Morinidazole was approved by China Food and Drug Administration (CFDA) on February 24, 2014. Morinidazole is a nitroimidazoles antibiotic used to treat bacterial infections including appendicitis and pelvic inflammatory disease. Morinidazole is a nitroimidazoles antibiotic indicated for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
纯度:≥98%
CAS:92478-27-8